Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

Beta BlockersLabetalol100-400 mg Q12HAdminister Anytime During HD; Post HD if Hypotensive

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
328<53-912.9503.3-7.930.67<1 (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Halstenson C, Opsahl J, Pence T, et al. The disposition and dynamics of labetalol in patients on dialysis. Clinical pharmacology and therapeutics. 1986;40(4):462-8.
  • Inrig J. Antihypertensive agents in hemodialysis patients: a current perspective. Seminars in dialysis. 2010;23(3):290-7.